Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus

Bibliographic Details
Main Authors:	Mayr LM, Powell RL, Ngai JN, Nádas A, Nyambi PN
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Intrasubtype C superinfected individuals mount delayed and low-titer autologous neutralizing antibody responses prior to superinfection
by: Basu D, et al.
Published: (2012-09-01)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Murphy, M, et al.
Published: (2013)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Megan K Murphy, et al.
Published: (2013-02-01)

Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection
by: Mackenzie M Shipley, et al.
Published: (2021-07-01)

Recombination following superinfection by HIV-1.
by: Fang, G, et al.
Published: (2004)

HIV-1 superinfection--a word of caution.
by: Goulder, P, et al.
Published: (2002)

[Delta superinfection associated with leukemoid reaction and HIV]
by: Pont Barrio, F, et al.
Published: (1993)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
by: Archary, D, et al.
Published: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, D, et al.
Published: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, Derseree, et al.
Published: (2014)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary, D, et al.
Published: (2012)

Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
by: Todd Bradley, et al.
Published: (2016-01-01)

Host-mediated regulation of superinfection in malaria.
by: Portugal, S, et al.
Published: (2011)

Wolbachia superinfections and the expression of cytoplasmic incompatibility.
by: Sinkins, S, et al.
Published: (1995)

Host-mediated regulation of superinfection in malaria
by: Portugal, S, et al.
Published: (2011)

Removal of a superinfected intragastric balloon
by: Jeremy P. Farida, MD, et al.
Published: (2024-04-01)

OP 8.6 – 00166 Autologous neutralizing antibody responses in bnAb-treated rhesus macaques
by: K. Bar, et al.
Published: (2022-12-01)

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
by: Kshitij Wagh, et al.
Published: (2018-03-01)

Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.
by: de Silva, T, et al.
Published: (2012)

Superinfection in malaria: Plasmodium shows its iron will.
by: Portugal, S, et al.
Published: (2011)

Superinfection in malaria: Plasmodium shows its iron will
by: Portugal, S, et al.
Published: (2011)

Ecological Approach to Understanding Superinfection Inhibition in Bacteriophage
by: Karin R. H. Biggs, et al.
Published: (2021-07-01)

Superinfected and Ruptured Occipital Meningocele: Case Report
by: Badr Kabila MD, et al.
Published: (2023-10-01)

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

Continuous HIV-1 Escape from Autologous Neutralization and Development of Cross-Reactive Antibody Responses Characterizes Slow Disease Progression of Children
by: Stefania Dispinseri, et al.
Published: (2021-03-01)

PP 4.11 – 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption
by: E. Esmaeilzadeh, et al.
Published: (2022-12-01)

Neutralizing monoclonal antibodies for treatment of COVID-19
by: Taylor, PC, et al.
Published: (2021)

Wolbachia in the Culex pipiens group mosquitoes: introgression and superinfection.
by: Walker, T, et al.
Published: (2009)

The Role of Bacterial and Fungal Superinfection in Critical COVID-19
by: Tamara Seitz, et al.
Published: (2022-12-01)

Superinfection of Rectovaginal Endometriosis: Case Report and Review of the Literature
by: Marta Barba, et al.
Published: (2023-04-01)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
by: Murphy MK, et al.
Published: (2012-09-01)

Immunodominance hierarchy of influenza subtype-specific neutralizing antibody response as a hurdle to effectiveness of polyvalent vaccine
by: Hoyoung Lee, et al.
Published: (2018-10-01)

A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
by: Consuelo Garcia-Rodriguez, et al.
Published: (2018-03-01)

Maintenance of the latent reservoir by pyroptosis and superinfection in a fractional order HIV transmission model
by: Ana R Carvalho, et al.
Published: (2019-07-01)

Development and characterization of a panel of anti-idiotype antibodies to 1C10 that cross-neutralize HIV-1 subtype B viruses
by: Yu Kaku, et al.
Published: (2022-08-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Reply to: Hepcidin in malaria superinfection: can findings be translated to humans?
by: Portugal, S, et al.
Published: (2011)

Stochastic properties of a generalized superinfection model of the spread of disease /
by: 258250 Lee, P. A.
Published: (1988)

Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect
by: James J Bull, et al.
Published: (2024-12-01)